Related Experiment Video
Updated: Feb 12, 2026

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues
Published on: June 3, 2016
Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types
Sucharitha Iyer1, Sunita K Agarwal1
1Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland, USA.
Abstract:
Epigenetic regulation is emerging as a key feature in the molecular characteristics of various human diseases. Epigenetic aberrations can occur from mutations in genes associated with epigenetic regulation, improper deposition, removal or reading of histone modifications, DNA methylation/demethylation and impaired non-coding RNA interactions in chromatin. Menin, the protein product of the gene causative for the multiple endocrine neoplasia type 1 (MEN1) syndrome, interacts with chromatin-associated protein complexes and also regulates some non-coding RNAs, thus participating in epigenetic control mechanisms. Germline inactivating mutations in the MEN1 gene that encodes menin predispose patients to develop endocrine tumors of the parathyroids, anterior pituitary and the duodenopancreatic neuroendocrine tissues. Therefore, functional loss of menin in the various MEN1-associated endocrine cell types can result in epigenetic changes that promote tumorigenesis. Because epigenetic changes are reversible, they can be targeted to develop therapeutics for restoring the tumor epigenome to the normal state. Irrespective of whether epigenetic alterations are the cause or consequence of the tumorigenesis process, targeting the endocrine tumor-associated epigenome offers opportunities for exploring therapeutic options. This review presents epigenetic control mechanisms relevant to the interactions and targets of menin, and the contribution of epigenetics in the tumorigenesis of endocrine cell types from menin loss.
Insights
Menin protein loss, caused by MEN1 gene mutations, leads to epigenetic changes that drive endocrine tumor development. Targeting these reversible epigenetic alterations offers potential therapeutic strategies for multiple endocrine neoplasia type 1.
Area of Science:
- Endocrinology
- Epigenetics
- Oncology
Background:
- Epigenetic regulation plays a crucial role in human diseases, involving mechanisms like DNA methylation and histone modifications.
- Menin, encoded by the MEN1 gene, is involved in epigenetic control through chromatin interactions and non-coding RNA regulation.
- Mutations in the MEN1 gene cause multiple endocrine neoplasia type 1 (MEN1) syndrome, predisposing to endocrine tumors.
Purpose of the Study:
- To review epigenetic control mechanisms involving menin.
- To explore the role of epigenetics in endocrine tumorigenesis resulting from menin loss.
- To highlight the therapeutic potential of targeting epigenetic alterations in MEN1-associated tumors.
Main Methods:
- Review of scientific literature on menin, epigenetics, and endocrine tumors.
- Analysis of menin's interactions with chromatin-associated complexes and non-coding RNAs.
- Discussion of epigenetic changes in endocrine cell types following menin loss.
Main Results:
- Menin participates in epigenetic regulation by interacting with chromatin modifiers and regulating non-coding RNAs.
- Loss of menin function due to MEN1 mutations leads to epigenetic dysregulation, promoting endocrine tumorigenesis.
- Epigenetic alterations in MEN1-associated tumors are potentially reversible and targetable.
Conclusions:
- Menin is a key player in epigenetic control relevant to endocrine development and tumor suppression.
- Epigenetic changes are critical in the pathogenesis of MEN1-associated endocrine tumors.
- Targeting the epigenome presents a promising therapeutic avenue for MEN1 syndrome and related endocrine neoplasms.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Endocrine Signaling
What is the Endocrine System?
The Endocrine System
An Overview of the Endocrine System
The endocrine system collaborates...

